Prophylactic intravesical instillation of mitomycin C and cytosine arabinoside for prevention of recurrent bladder tumors following surgery for upper urinary tract tumors: A prospective randomized study

International Journal of Urology

Volumn 8, Issue 5, 2001, Pages 212-216

  Sakamoto, Naotaka ^a   Naito, Seiji ^a   Kumazawa, Joichi ^a   Ariyoshi, Asami ^b   Osada, Yukio ^c   Omoto, Tetsuo ^d   Fujisawa, Yasuhito ^e   Morita, Ichikirou ^f   Yamashita, Hiroshi ^g  

^a KYUSHU UNIVERSITY   (Japan)

^b FUKUOKA UNIVERSITY   (Japan)

^c UNIVERSITY OF MIYAZAKI   (Japan)

^d KYUSHU KOSEI NENKIN HOSPITAL   (Japan)

^e ASO IIZUKA HOSPITAL   (Japan)

^f NATIONAL HOSPITAL ORGANIZATION KYUSHU MEDICAL CENTER   (Japan)

^g Ekisaikai Hospital   (Japan)

Author keywords

Bladder tumor; Prophylactic intravesical instillation; Renal pelvic and ureter rumor

Indexed keywords

CYTARABINE; MITOMYCIN C;

ADULT; AGED; ARTICLE; BLADDER TUMOR; CANCER COMBINATION CHEMOTHERAPY; CANCER PREVENTION; CANCER RECURRENCE; CLINICAL ARTICLE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DRUG INSTILLATION; FEMALE; FOLLOW UP; HUMAN; MALE; MULTIVARIATE ANALYSIS; POSTOPERATIVE CARE; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL; RECURRENCE RISK; STATISTICAL SIGNIFICANCE; TRANSITIONAL CELL CARCINOMA; TUMOR RECURRENCE; URINARY TRACT CARCINOMA;

ADMINISTRATION, INTRAVESICAL; AGED; AGED, 80 AND OVER; ANTIBIOTICS, ANTINEOPLASTIC; ANTIMETABOLITES, ANTINEOPLASTIC; ANTINEOPLASTIC COMBINED CHEMOTHERAPY PROTOCOLS; CARCINOMA, TRANSITIONAL CELL; CYTARABINE; FEMALE; HUMANS; KIDNEY NEOPLASMS; MALE; MIDDLE AGED; MITOMYCIN; PROSPECTIVE STUDIES; URETERAL NEOPLASMS; URINARY BLADDER NEOPLASMS;

EID: 0035569273     PISSN: 09198172     EISSN: None     Source Type: Journal    
DOI: 10.1046/j.1442-2042.2001.00286.x     Document Type: Article

References (15)

1. Recurrence of bladder tumors following surgery for transitional cell carcinoma of the upper urinary tract
2. Transitional cell carcinoma of the upper urinary tract: Prognostic variables and postoperative recurrences
3. Japanese urological cancer research for adriamycin. Randomized clinical trial on chemoprophylaxis of recurrence in cases of superficial bladder cancer
4. Postoperative prophylactic intravesical instillation of cytosine arabinoside and mitomycin C in superficial bladder tumor: A follow-up study
5. Prophylactic intravesicai chemotherapy for bladder tumor after surgery of upper tract urothelial carcinoma
6. Prophylactic intravesical BCG for bladder tumor after surgery of upper tract urothelial carcinoma
7. Urological tumors: Renal pelvis and ureter
8. Tumor grade and stage as prognostic variables in upper tract urothelial tumors
9. Life tables with concomitant information
10. Prophylaxis of bladder tumor implantation: Intravesical and systematic chemotherapy
11. Rationale for intensive intravesical chemotherapy for superficial bladder cancer
12. Prophylactic chemotherapy of superficial transitional cell bladder carcinoma: An EORTC randomized trial comparing thiotepa, an epipodophyllotoxin (VM 26) and TUR alone
13. p53 mutations in multiple urothelial carcinomas: A molecular analysis of the development of multiple carcinomas
14. Intravesical chemotherapy and immunotherapy for superficial tumors: Basic mechanism of action and future direction
15. Intravesical chemotherapy for maximum prophylaxis of new early phase superficial bladder carcinoma treated by transurethral resection: A combined analysis of trials by the Japanese Urological Cancer Research Group using smoothed hazard function